AU6642996A - Biomarkers and targets for diagnosis, prognosis and management of prostate disease - Google Patents

Biomarkers and targets for diagnosis, prognosis and management of prostate disease

Info

Publication number
AU6642996A
AU6642996A AU66429/96A AU6642996A AU6642996A AU 6642996 A AU6642996 A AU 6642996A AU 66429/96 A AU66429/96 A AU 66429/96A AU 6642996 A AU6642996 A AU 6642996A AU 6642996 A AU6642996 A AU 6642996A
Authority
AU
Australia
Prior art keywords
biomarkers
prognosis
targets
diagnosis
management
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU66429/96A
Other versions
AU712403B2 (en
Inventor
Gang An
S. Mark O'hara
David Ralph
Robert Veltri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urocor Inc
Original Assignee
Urocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urocor Inc filed Critical Urocor Inc
Priority claimed from PCT/US1996/012516 external-priority patent/WO1998004689A1/en
Publication of AU6642996A publication Critical patent/AU6642996A/en
Application granted granted Critical
Publication of AU712403B2 publication Critical patent/AU712403B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU66429/96A 1996-07-31 1996-07-31 Biomarkers and targets for diagnosis, prognosis and management of prostate disease Ceased AU712403B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/012516 WO1998004689A1 (en) 1995-07-31 1996-07-31 Biomarkers and targets for diagnosis, prognosis and management of prostate disease

Publications (2)

Publication Number Publication Date
AU6642996A true AU6642996A (en) 1998-02-20
AU712403B2 AU712403B2 (en) 1999-11-04

Family

ID=22255530

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66429/96A Ceased AU712403B2 (en) 1996-07-31 1996-07-31 Biomarkers and targets for diagnosis, prognosis and management of prostate disease

Country Status (3)

Country Link
AT (1) ATE311450T1 (en)
AU (1) AU712403B2 (en)
DE (1) DE69635526T2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113633A (en) * 2021-12-27 2022-03-01 复旦大学 Molecular index and kit for prostate cancer risk degree diagnosis and curative effect evaluation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262311A (en) * 1992-03-11 1993-11-16 Dana-Farber Cancer Institute, Inc. Methods to clone polyA mRNA
US5639656A (en) * 1994-03-31 1997-06-17 Medical College Of Hampton Road Antibodies reactive with biological markers of benign prostate hyperplasia
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113633A (en) * 2021-12-27 2022-03-01 复旦大学 Molecular index and kit for prostate cancer risk degree diagnosis and curative effect evaluation
CN114113633B (en) * 2021-12-27 2024-05-24 复旦大学 Molecular index and kit for diagnosing risk and evaluating curative effect of prostate cancer

Also Published As

Publication number Publication date
DE69635526T2 (en) 2006-08-17
AU712403B2 (en) 1999-11-04
ATE311450T1 (en) 2005-12-15
DE69635526D1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
AU4560499A (en) Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
EP1090291A4 (en) Method for early diagnosis of, and determination of prognosis in, cancer
AU3897999A (en) Multi-analyte diagnostic system and computer implemented process for same
AU6409799A (en) Tissue analysis and kits therefor
AU1724000A (en) Diagnostic assay for cancer
AU2922497A (en) Detection probes, kits and assays
AU6688598A (en) Method for diagnosing and staging prostate cancer
AU2149700A (en) Systems for the analysis of gene expression data
AU1748597A (en) Disk caching disk
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU1662100A (en) System and method for the optimization of data collection
AU5291098A (en) Pipe lining method
AU1810899A (en) Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU2735797A (en) Detection probes, kits and assays
AU3944497A (en) 1,2-diarylindole as cox-2 inhibitors
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
AU2218199A (en) Method for identifying validated target and assay combinations
AU1930099A (en) Tokenless financial access system
AU3364899A (en) Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2714500A (en) Method and system for target register allocation
AU6642996A (en) Biomarkers and targets for diagnosis, prognosis and management of prostate disease
AU6214199A (en) Pipe liner and pipe lining method
AU3239895A (en) Method of using hyaluronic acid for the detection, location and diagnosis of tumors

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)